OpenMed/OpenMed NER PharmaDetect BigMed 278M
Advanced NLP model for pharmaceutical entity recognition
Pricing
See website
Flat rate
Adoption
→StableLicense
Open Source
Data freshness
—Overview
What is OpenMed/OpenMed NER PharmaDetect BigMed 278M?
This AI-native model specializes in Named Entity Recognition (NER) within the pharmaceutical domain, offering precise identification of entities from large medical datasets. It is crucial for researchers and developers working on applications that require accurate extraction of drug names, diseases, and other relevant information.
Key differentiator
“This model stands out for its specialized focus on pharmaceutical entities, providing high accuracy in recognizing drug names and diseases from large medical datasets.”
Capability profile
Strength Radar
Honest assessment
Strengths & Weaknesses
↑ Strengths
Fit analysis
Who is it for?
✓ Best for
Teams working on pharmaceutical NLP tasks who need high precision and recall
Developers building applications that require accurate extraction of drug names from text
✕ Not a fit for
Projects requiring real-time entity recognition without the ability to self-host models
Applications needing a wide range of language support beyond English
Cost structure
Pricing
Free Tier
None
Starts at
See website
Model
Flat rate
Enterprise
None
Performance benchmarks
How Fast Is It?
Next step
Get Started with OpenMed/OpenMed NER PharmaDetect BigMed 278M
Step-by-step setup guide with code examples and common gotchas.